The Cancer Genetic Markers of Susceptibility (CGEMS) prostate cancer genome-wide association study (GWAS) included genotyping approximately 550,000 SNPs (Phase 1A with HumanHap300 and Phase 1B HumanHa
This study aims to unveil the comprehensive germline mutation landscape in Chinese prostate cancer patients. The study will provide a comprehensive germline mutation profile of Chinese prostate cancer
Participants were recruited through the Ghana Prostate Study-a population-based component, and a clinical component. The population-based component was a probability sample designed using the 2000 Gha
* Genes indicated in bold are on the genes flanking prostate cancer risk variants. Gene-gene interaction networks and associated diseases and biological functions among genes flanking prostate cancer
This study aims to elucidate the genetic determinants of susceptibility to aggressive prostate carcinoma. To this end, germ line whole exome sequence has been generated from patients with aggressive p
